The global Upper Extremity Implants Market size is anticipated to reach USD 2.28 billion by
2030 and is projected to grow at a CAGR of 4.0% during the forecast period,
according to a new report by Grand View Research, Inc. The rising prevalence of
musculoskeletal disorders significantly influences the upper extremity implant
market. Conditions such as arthritis, tendonitis, and osteoporosis are becoming
more common, particularly among the aging population. According to a WHO report
from July 2022, around 1.71 billion people globally suffer from musculoskeletal
conditions.
These disorders
often lead to impaired mobility and chronic pain, necessitating medical
intervention and, in severe cases, surgical procedures involving implants. The
growing awareness of these conditions and the availability of advanced
diagnostic tools enable earlier detection and treatment, further driving the
demand for upper extremity implants. As the global population ages, the
incidence of musculoskeletal disorders is expected to increase, ensuring a
steady demand for implant solutions designed to restore function and improve
the quality of life for affected individuals.
Companies such as
Zimmer Biomet, Stryker, Johnson & Johnson, and Smith+Nephew are at the
forefront of introducing innovative implant solutions and advanced surgical
techniques. Technological advancements like 3D printing, robotics, and biocompatible materials are enhancing the
precision, durability, and functionality of implants, leading to improved
patient outcomes and reduced recovery times. For instance, in August 2022,
OSSIO, Inc. announced the launch and initial commercial use of OSSIOfiber
Anchors.
This introduction
expands patient access to OSSIO's growing portfolio of bio-integrative
implants, which are designed for use in shoulder, hand/wrist, and elbow
surgeries. These innovations enable the development of customized implants
tailored to individual patient needs, increasing the adoption of these devices.
The continuous efforts of these key players to innovate and improve implant
technology are pivotal in driving the expansion and the market evolution.
Furthermore, the
increasing participation in sports and physical activities has led to a higher
incidence of sports-related injuries, which in turn drives the demand for upper
extremity implants. Injuries such as fractures, dislocations, and ligament
tears are common among athletes and active individuals, often requiring
surgical intervention to restore functionality. The growing awareness of the
benefits of early and effective treatment for sports injuries has prompted more
individuals to seek medical help, leading to an increase in the number of
surgical procedures involving implants. Moreover, advancements in minimally
invasive surgical techniques and improved implant designs have made these
procedures more effective and accessible, further fueling market growth.
List of Key
Players in the Upper Extremity Implants Market
- Stryker
- DePuy
- Zimmer Biomet
- Smith & Nephew
- Medtronic
- Aesculap
- BioTek Instruments
- Conmed
- Arthrex, Inc.
- Ossur
- DJO Global
- Acumed LLC
Related Press Release@ Upper Extremity Implants Market Report
Upper Extremity
Implants Market Report Highlights
- The shoulder segment held the largest share of
59.52% in 2023. The segment's growth is propelled by a rise in sports
injuries, shoulder dislocations, a growing geriatric population,
increasing incidence of osteoarthritis, shoulder fractures, accidents, and
traumas, all contributing to higher demand for upper extremity implant
products
- The metallic biomaterials segment held the largest
share in 2023. This can be attributed to advanced properties such as
proper strength, fracture toughness, ductility, hardness, corrosion
resistance, and biocompatibility
- The hospitals segment held the largest share in 2023.
Innovations such as robotic-assisted surgery and advanced imaging
techniques enhance surgical accuracy and patient outcomes
- North America market dominated the overall global
market in 2023. Factors such as rising common shoulder injuries such as
include dislocations/separations, sprains/strains, contusions, and
fractures. The rise in the geriatric population, increasing number of
sports injuries, and presence of key participants in North America are
driving regional growth
- The competitive scenario in the market is highly
competitive, with key players holding significant positions. The major
companies are undertaking various strategies such as new product
development, collaborations, acquisitions, mergers, and regional expansion
to serve the unmet needs of their customers
Upper Extremity Implants Market
Report Scope
Report Attribute |
Details |
Market
size value in 2024 |
USD 1.80
billion |
Revenue
forecast in 2030 |
USD 2.28
billion |
Growth
rate |
CAGR of
4.0% from 2024 to 2030 |
Actual
data |
2018 -
2023 |
Forecast data |
2024 - 2030 |
Upper Extremity
Implants Market Segmentation
Grand View
Research has segmented the global upper extremity implants market based on
type, biomaterial, end-use, and region:
Upper Extremity
Implants Type Outlook (Revenue, USD Million, 2018 - 2030)
- Shoulder
- Elbow
- Hand & Wrist
Upper Extremity
Implants Biomaterial Outlook (Revenue, USD Million, 2018 - 2030)
- Metallic Biomaterials
- Ceramic Biomaterials
- Polymeric Biomaterials
- Natural Biomaterials
Upper Extremity
Implants End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- ASCs
- Clinics
Upper Extremity
Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina Mexico
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key
Players in the Upper Extremity Implants Market
- Stryker
- DePuy
- Zimmer Biomet
- Smith & Nephew
- Medtronic
- Aesculap
- BioTek Instruments
- Conmed
- Arthrex, Inc.
- Ossur
- DJO Global
- Acumed LLC
Explore Horizon, the world's most expansive market research database
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment